Back to mobile site

Celgene (CELG) to Acquire Juno Therapeutics (JUNO) for $87/Share

January 22, 2018 6:30 AM EST Send to a Friend
Celgene Corporation (NASDAQ: CELG) and Juno Therapeutics, Inc. (NASDAQ: JUNO) today announced the signing of a definitive merger agreement in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login